Fluoxetine, smoking, and history of major depression: A randomized controlled trial. |
| |
Authors: | Spring, Bonnie Doran, Neal Pagoto, Sherry McChargue, Dennis Cook, Jessica Werth Bailey, Katherine Crayton, John Hedeker, Donald |
| |
Abstract: | The study was a randomized placebo-controlled trial testing whether fluoxetine selectively enhances cessation for smokers with a history of depression. Euthymic smokers with (H+, n = 109) or without (H-, n = 138) a history of major depression received 60 mg fluoxetine or placebo plus group behavioral quit-smoking treatment for 12 weeks. Fluoxetine initially enhanced cessation for H+ smokers (p = .02) but subsequently impaired cessation regardless of depressive history. Six months after quit date, fluoxetine-treated participants were 3.3 times more likely to be smoking (p = .02). Further research is warranted to determine why high-dose fluoxetine produces continuing effects that oppose tobacco abstinence. (PsycINFO Database Record (c) 2010 APA, all rights reserved) |
| |
Keywords: | tobacco smoking cessation depression fluoxetine randomized controlled trial |
|
|